Skip to main content
Livermore
Livermore
ZHEN

Macquarie Group Ltd

SEC CIK
0001418333
Latest filing
Aug 14, 2026

MDGL holding history

Madrigal Pharmaceuticals, Inc. in every 13F filed by Macquarie Group Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MDGL overviewAll 13F holders of MDGLFull Q2 2026 holdings

Shares (Q2 2026)
32
Value
$17.2K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of MDGL by Macquarie Group Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202632$17.2K<0.1%+32NewHolders
Q4 20250$00.0%−13,493−100.0%Sold outHolders
Q3 202513,493$6.19M<0.1%−6,150−31.3%ReducedHolders
Q2 202519,643$5.95M<0.1%+4,643+31.0%AddedHolders
Q1 202515,000$4.97M<0.1%00.0%UnchangedHolders
Q4 202415,000$4.63M<0.1%00.0%UnchangedHolders
Q3 202415,000$3.18M<0.1%−13,500−47.4%ReducedHolders
Q2 202428,500$7.99M<0.1%−30,457−51.7%ReducedHolders
Q1 202458,957$15.7M<0.1%+30,457+106.9%AddedHolders
Q4 202328,500$6.59M<0.1%00.0%UnchangedHolders
Q3 202328,500$4.16M<0.1%00.0%UnchangedHolders
Q2 202328,500$6.58M<0.1%00.0%UnchangedHolders
Q1 202328,500$6.90M<0.1%00.0%UnchangedHolders
Q4 202228,500$8.27M<0.1%−849−2.9%ReducedHolders
Q3 202229,349$1.92M<0.1%−145−0.5%ReducedHolders
Q2 202229,494$2.11M<0.1%00.0%UnchangedHolders
Q1 202229,494$2.89M<0.1%00.0%UnchangedHolders
Q4 202129,494$2.50M<0.1%00.0%UnchangedHolders
Q3 202129,494$2.35M<0.1%+743+2.6%AddedHolders
Q2 202128,751$2.80M<0.1%00.0%UnchangedHolders
Q1 202128,751$3.36M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.